Preliminary preclinical studies have shown that Rho-related signaling pathways play an essential role in the pathogenesis of ALI, and Rho kinase inhibitors have good potential in alleviating the disease of ALI and can bring considerable benefits. This evidence concerns the gene RHO and acute respiratory distress syndrome.